UEU-co logo

MD Consult: Books: Goldman: Cecil Medicine: REFERENCES

Goldman: Cecil Medicine, 23rd ed.

Copyright © 2007 Saunders, An Imprint of Elsevier


1. Shapiro DE, Sperling RS, Mandelbrot L, et al: Risk factors for perinatal human immunodeficiency virus transmission in patients receiving zidovudine prophylaxis: Pediatric AIDS Clinical Trials Group protocol 076 Study Group.  Obstet Gynecol  1999; 94:897-908.

2. Connor EM, Sperling RS, Gelber R, et al: Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment.  N Engl J Med  1994; 331:1173-1180.

3. Lallemant M, Jourdain G, Le Coeur S, et al: A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1.  N Engl J Med  2000; 343:982-991.

4. Guay LA, Musoke P, Fleming T, et al: Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.  Lancet  1999; 354:795-802.

5. Volmink J, Siegfried N, van der Merwe L, et al: Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.  Cochrane Database Syst Rev  2007;1.CD003510

Email to Colleague Print Version

Copyright © 2007 Elsevier Inc. All rights reserved. –

Leave a Reply

Time limit is exhausted. Please reload the CAPTCHA.


apply_now Pepperstone Group Limited